tm
Seeing Is Believing
tm
Seeing Is Believing
FATE is currently covered by 17 analysts with an average price target of $9.92. This is a potential upside of $8.32 (520%) from yesterday's end of day stock price of $1.6.
Fate Therapeutics's activity chart (see below) currently has 216 price targets and 189 ratings on display. The stock rating distribution of FATE is 74.29% HOLD, 22.86% BUY and 2.86% SELL.
Analysts average stock forecasts to be materialized ratio is 61.43% with an average time for these price targets to be met of 122.28 days.
Highest price target for FATE is $6, Lowest price target is $2, average price target is $5.38.
Most recent stock forecast was given by PETER LAWSON from BARCLAYS on 14-May-2025.
Currently out of the existing stock ratings of FATE, 26 are a HOLD (74.29%), 8 are a BUY (22.86%), 1 are a SELL (2.86%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$2
$0.79 (65.29%)
$10
23 days ago
(14-May-2025)
6/9 (66.67%)
$1.04 (108.33%)
91
Hold
$5
$3.79 (313.22%)
$5
3 months ago
(06-Mar-2025)
8/12 (66.67%)
$4.09 (449.45%)
143
Hold
$4
$2.79 (230.58%)
$5
3 months ago
(06-Mar-2025)
2/3 (66.67%)
$3.09 (339.56%)
49
Hold
$3
$1.79 (147.93%)
$5
3 months ago
(06-Mar-2025)
7/13 (53.85%)
$2.09 (229.67%)
54
Hold
$6
6 months 19 days ago
(18-Nov-2024)
2/3 (66.67%)
$-1.34 (-18.26%)
111
What is FATE (Fate Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on FATE (Fate Therapeutics) with a proven track record?
Which analyst has the most public recommendations on FATE (Fate Therapeutics)?
Which analyst is the currently most bullish on FATE (Fate Therapeutics)?
Which analyst is the currently most reserved on FATE (Fate Therapeutics)?
